Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 52, 2022 - Issue 6
Submit an article Journal homepage
158
Views
0
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

In vivo evaluation of pharmacokinetic drug–drug interactions between fluorinated pyrimidine anticancer drugs, 5-fluorouracil and capecitabin, and an anticoagulant, warfarin

Ai HasegawaDepartment of Clinical Pharmacy, Mukogawa Women’s University, Nishinomiya, JapanView further author information
,
Yoshie TsujiyaDepartment of Clinical Pharmacy, Mukogawa Women’s University, Nishinomiya, JapanView further author information
,
Ayaka UedaDepartment of Clinical Pharmacy, Mukogawa Women’s University, Nishinomiya, JapanView further author information
,
Motohiro YamamoriDepartment of Clinical Pharmacy, Mukogawa Women’s University, Nishinomiya, JapanView further author information
&
Noboru OkamuraDepartment of Clinical Pharmacy, Mukogawa Women’s University, Nishinomiya, JapanCorrespondence[email protected]
View further author information
Pages 608-612 | Received 01 Jul 2022, Accepted 25 Aug 2022, Published online: 01 Sep 2022

References

  • Afsar A, Lee C, Riddick DS. 1996. Modulation of the expression of constitutive rat hepatic cytochrome P450 isozymes by 5-fluorouracil. Can J Physiol Pharmacol. 74(2):150–156.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
  • Camidge R, Reigner B, Cassidy J, Grange S, Abt M, Weidekamm E, Jodrell D. 2005. Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer. J Clin Oncol. 23(21):4719–4725.
  • Copur MS, Ledakis P, Bolton M, Morse AK, Werner T, Norvell M, Muhvic J, Chu E. 2001. An adverse interaction between warfarin and capecitabine: a case report and review of the literature. Clin Colorectal Cancer. 1(3):182–184.
  • Cronin-Fenton DP, Søndergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J, Baron JA, Sørensen HT. 2010. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006. Br J Cancer. 103(7):947–953.
  • Fukuno S, Nagai K, Kasahara K, Mizobata Y, Omotani S, Hatsuda Y, Myotoku M, Konishi H. 2018. Altered tolbutamide pharmacokinetics by a decrease in hepatic expression of CYP2C6/11 in rats pretreated with 5-fluorouracil. Xenobiotica. 48(1):53–59.
  • Kolesar JM, Johnson CL, Freeberg BL, Berlin JD, Schiller JH. 1999. Warfarin-5-FU interaction–a consecutive case series. Pharmacotherapy. 19(12):1445–1449.
  • Miura M, Okuyama S, Kato S, Kagaya H, Murata A, Komatsuda A, Wakui H, Sawada K. 2011. Simultaneous determination of warfarin and 7-hydroxywarfarin enantiomers by high-performance liquid chromatography with ultraviolet detection. Ther Drug Monit.33(1):108–114.
  • O’Reilly RA. 1974. Studies on the optical enantiomorphs of warfarin in man. Clin Pharmacol Ther. 16(2):348–354.
  • Park JY, Kim KA. 2003. Inhibitory effect of 5-fluorouracil on human cytochrome P(450) isoforms in human liver microsomes. Eur J Clin Pharmacol. 59(5–6):407–409.
  • Saif MW. 2005. An adverse interaction between warfarin and fluoropyrimidines revisited. Clin Colorectal Cancer. 5(3):175–180.
  • Smith GF, Neubauer BL, Sundboom JL, Best KL, Goode RL, Tanzer LR, Merriman RL, Frank JD, Herrmann RG. 1988. Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the rat. Thromb Res. 50(1):163–174.
  • Ye H, Sui D, Liu W, Yuan Y, Ouyang Z, Wei Y. 2019. Effects of CYP2C11 gene knockout on the pharmacokinetics and pharmacodynamics of warfarin in rats. Xenobiotica. 49(12):1478–1484.
  • Zhou Q, Chan E. 2002. Effect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats. Eur J Pharm Sci. 17(1–2):73–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.